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Background: Our prior characterization of RasGrf1 deficient mice uncovered significant defects in pancreatic islet
count and size as well as beta cell development and signaling function, raising question about the mechanisms
linking RasGrf1 to the generation of those “pancreatic” phenotypes.
Results: Here, we compared the transcriptional profile of highly purified pancreatic islets from RasGrf1 KO
mice to that of WT control animals using commercial oligonucleotide microarrays. RasGrf1 elimination
resulted in differential gene expression of numerous components of MAPK- and Calcium-signaling pathways,
suggesting a relevant contribution of this GEF to modulation of cellular signaling in the cell lineages
integrating the pancreatic islets. Whereas the overall transcriptional profile of pancreatic islets was highly
specific in comparison to other organs of the same KO mice, a significant specific repression of Pttg1 was
a common transcriptional alteration shared with other tissues of neuroectodermal origin. This observation,
together with the remarkable pancreatic phenotypic similarities between RasGrf1 KO and Pttg1 KO mice
suggested the possibility of proximal functional regulatory links between RasGrf1 and Pttg1 in pancreatic
cell lineages expressing these proteins.
Analysis of the mPttg1 promoter region identified specific recognition sites for numerous transcription
factors which were also found to be differentially expressed in RasGrf1 KO pancreatic islets and are known
to be relevant for Ras-ERK signaling as well as beta cell function. Reporter luciferase assays in BT3 insulinoma
cells demonstrated the ability of RasGrf1 to modulate mPttg1 promoter activity through ERK-mediated signals.
Analysis of the phenotypic interplay between RasGrf1 and Pttg1 in double knockout RasGrf1/Pttg1 mice showed
that combined elimination of the two loci resulted in dramatically reduced values of islet and beta cell count
and glucose homeostasis function which neared those measured in single Pttg1 KO mice and were significantly
lower than those observed in individual RasGrf1 KO mice.
Conclusions: The specific transcriptional profile and signaling behavior of RasgGrf1 KO pancreatic islets,
together with the dominance of Pttg1 over RasGrf1 with regards to the generation of these phenotypes in
mouse pancreas, suggest that RasGrf1 is an important upstream component of signal transduction pathways
regulating Pttg1 expression and controlling beta cell development and physiological responses.
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RasGrf1 is a mammalian guanine nucleotide exchange
factor (GEF) for Ras GTPases [1-3] which is specifically
expressed at central nervous system locations, testis and
pancreas (CNS) [4,5], although various isoforms thereof
are also expressed in a variety of other tissues [6].
RasGrf1 specifically promotes GDP/GTP exchange on
various members of the Ras GTPase family including
the three canonical Ras isoforms (H, N and K), M-Ras,
R-Ras, [7,8], and Rac [9]. The RasGrf1 proteins act by
coupling different upstream stimuli to activation of vari-
ous intracellular pathways through the specific contri-
bution of some of its structural domains, including the
CDC25-H domain capable of activating Ras family
members, the Ca+2/Calmodulin interacting IQ domain
[5,10], two PH domains, or a DH (Dbl homology) domain
capable of activating Rho/Rac family GTPases [10]. Due to
this complex domain structure, RasGrf1 is able to couple
Ras activation to different signal transduction processes,
such as those mediated by Ca2+/calmodulin [1,11], hetero-
trimeric G proteins [12], cAMP activity [13], CDC42 [14],
or even non-receptor tyrosine kinases [15].
RasGrf1 KO mice exhibit defects in memory consoli-
dation [3], reduced body size, deficiency of IGF-1 and
growth hormone, and hypoinsulinemia [16,17]. Our
analysis of the RasGrf1 KO mice showed significant
reduction of pancreatic islet number and size, linked to
diminished beta cell proliferation and neogenesis, and
resulting in hypoinsulinemia, glucose intolerance and
prediabetic state [17]. RasGrf1 elimination is also associ-
ated to defective eye phenotypes including impaired ret-
inal photoreception [18] and altered lens growth [19].
Multiple reports suggest the participation of Ras signal-
ing pathways, and RasGrf1 in particular, in the control of
pancreatic islet and beta cell development and function.
For example, male transgenic mice overexpressing human
H-Ras develop β-cell degeneration and onset of diabetes,
exhibiting hyperglycemia, glycosuria, and hypoinsulinemia
[20], and Ras inhibition in mouse cells leads to increased
insulin sensitivity and glucose uptake [21]. It has also been
shown in human islet cells that glucose and glucagon-like
peptide-1 activate the Rap/B-Raf signaling module, thus
mediating ERK and phosphoinositide 3-kinase activation
[22]. Additional reports have also demonstrated the par-
ticipation of Ras signaling in the response of beta cells to
prolactin [23] and the contribution of HNF-4a, RasGrf1
and other putative RasGEFs, such as ST5, as modulators
of Ras/ERK activity in those cells [24]. Furthermore,
RasGrf1 has also been implicated in insulin secretion
induced by the transient diabetes mellitus gene Zac1
[25]. Finally, our observations in small-bodied RasGrf1
KO mice of hypoinsulinemia, reduced pancreatic beta
cell mass, and defective activation of Ras signaling
after stimulation of isolated islet cells with IGF1, arealso strongly indicative of an essential role of RasGrf1
in beta cell proliferation and neogenesis [17,26]. In this
regard, the very strong similarity observable between
the pancreatic phenotypes of our RasGrf1 KO mice
and those exhibited by Cdk4 KO mice [27,28], p70S6K
KO mice [29,30] or Pttg1KO mice [31] is very striking,
suggesting the possible joint participation of RasGrf1
and those different signaling molecules in the same
Ras-dependent signaling pathways [1].
In order to better understand the role of Ras signal-
ing in pancreatic islet and beta cell function and to
characterize the transcriptional changes underlying the
phenotypic pancreatic alterations observed in our RasGrf1
KO mice, we aimed at characterizing the genomic expres-
sion profiles linked to the disappearance of RasGrf1 from
pancreatic β cells in our KO mice. For this purpose, we
used commercial oligonucleotide microarrays in order
to carry out a detailed comparison between the genomic
expression profiles of highly purified preparations of
pancreatic islets isolated from our Wild Type (WT) and
Knockout (KO) RasGrf1 mice [17,26,32]. The data gen-
erated here supports the notion of significant functional
roles of RasGrf1 in control of pancreatic islet signaling
processes, as the absence of this RasGEF was clearly
linked to multiple transcriptomic alterations affecting
genes whose products are known to be highly relevant
for cellular signaling pathways of pancreatic beta cells
involving Ras/ERK activation and intracellular calcium
movement. In addition, our data also suggests that the
functional role of RasGrf1 in pancreatic islets is mech-
anistically mediated, at least in part, by Pttg1, a known
regulator of mitosis and gene expression.
Results and discussion
Differential gene expression in RasGrf1 KO pancreatic islets
For a full characterization of the transcriptional profiles
of purified islets from the pancreas of Wild Type and
RasGrf1 KO mice, we first determined RasGrf1 mRNA
and protein expression levels in isolated mouse islets
(Figure 1). Thus, RT-PCR analysis of purified RNA from
wild type and RasGrf1 KO pancreatic islets showed that
RasGrf1 mRNA is strongly expressed in wild type islets
and, as expected, its expression was totally lost in the
KO islets (Figure 1A). Furthermore, a similar RasGrf1
expression pattern was observed at the protein level, as
Western blot analysis of islet protein immunoprecipitates
allowed detection of the full size 140 kDa RasGrf1 protein
band in wild type islets, which was completely absent in
the RasGrf1 KO samples. Interestingly, RasGrf2 expression
was also observed in pancreatic islets and appeared to be
slightly diminished upon RasGrf1 elimination (Figure 1B).
Smaller-sized RasGrf1 protein forms that have been
described elsewhere [33,34] were not detected by this
technique in our mice islets.
Figure 1 RasGrf1 expression in pancreatic islets. (A) RT-PCR
amplification of the RasGrf1 locus. Total RNA samples from pancreatic
islet preparations isolated from RasGrf1 knockout (KO) or wild type
(WT) mice were tested by means of RT-PCR assays using oligonucleotides
LM5 and LM85 (described in Methods) designed to amplify a
specific 276 bp fragment corresponding to the catalytic domain
of RasGrf1. C: negative control. MWM: molecular weight markers.
(B) Analysis of RasGrf1/2 protein expression. Total protein extracts from
WT and RasGrf1 KO pancreatic islets were immunoprecipitated
with anti-RasGrf1/2 antibody and later submitted to SDS-PAGE
followed by Western immunoblot with the same antibody
(see Methods). The amount of protein in each lane was controlled and
normalized by means of Western immunoblots using specific
alpha-actin antibodies (lower panel).
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ant contributors to islet cell physiology in processes of
regulation of cellular proliferation [17,24] and response
to prolactin [23]. To gain further insight into the mo-
lecular events occurring in islets modulated by RasGrf1,
we compared the genomic expression profiles of Wild
Type and RasGrf1 KO islets. Our preliminary studies
indicated that minimal contamination of exocrine cells in
our islet preparations would significantly bias data result-
ing from the microarray hybridizations and therefore we
assessed an additional quantitative method to control the
purity of islets samples as previously described [35]. Thus,
before use in microarray hybridizations, the specificity and
purity of the RNA preparations from islet cells used in our
microarray hybridizations were tested by measuring thenormalized signal ratios obtained in Real-time PCR
analyses of the total RNA sample preparations with spe-
cific primer probes for insulin (specifically expressed in
islet beta cells) and amylase (expressed throughout the
pancreas), which indicated an enrichment of about 20000
fold for our islet RNA preparations in comparison to RNA
extracted from total pancreases (Figure 2A).
Six independent microarray hybridizations were per-
formed using total RNA preps extracted from pancreatic
islets of WT and RasGrf1 KO mice. Global expression data
were analyzed using RMA [36] as a tool allowing simultan-
eous background correction, multichip normalization and
quantization of probeset expression signals in all separate
microarray hybridizations. Statistically significant gene
expression changes occurring in RasGrf1 KO islets were
identified using the SAM algorithm [37]. In order to
facilitate comparison of these data with our previous
microarray analyses of other tissues of RasGrf1 KO mice
[18,32] and to get a manageable list of genes for further
functional analysis, we set the false discovery rate (FDR)
[38] value at 0.084, which allowed identification of a
total of 4525 differentially expressed gene probesets
(corresponding to 3686 distinct genes) in the RasGrf1
KO islets (Figure 2B). A dendrogram generated by hier-
archical clustering of all microarray hybridization data
sets generated with all our WT and RasGrf1 KO samples
(Figure 2C) showed clear discrimination between the
WT and the KO islet RNAs as well as a generally opposite
pattern of differential mRNA expression between these
two genotypes. In addition, functional annotation analysis
identified significant enrichment of genes related to rele-
vant biological functions in the horizontal clusters defined
by the dendrogram (Figure 2C). These observations indi-
cate that the elimination of RasGrf1 in pancreatic islets
produces significant transcriptional changes in a wide set
of genes and suggesting a critical role for this GEF in the
regulation of specific pancreatic endocrine functions.
A detailed description of all the induced or repressed
probesets detected in pancreatic islets is provided in
Table S1 (Additional file 1), where the R-fold changes
and statistical significance parameters relative to each of
the 4525 differentially expressed probesets are provided.
Overall, about half of differentially expressed loci (2268
probesets, corresponding to 1953 distinct genes) were
downregulated, whereas the other half (2256 probesets,
corresponding to 1799 distinct genes) were up-regulated
in the mRNA population of the RasGrf1 KO islets as
compared to their WT control counterparts (Additional
file 1: Table S1, Figure 2C).
In view of the neuroendocrine nature of the hormone-
making islet cells [39] it was remarkable that the two
genes showing highest levels of transcriptional repression
(by d-value and R-fold) in our RasGrf1 KO islet samples
(Additional file 1: Table S1) are Gdpd3 (glycerophosphodiester
Figure 2 Transcriptional analysis of WT and RasGrf1 KO pancreatic islets by microarrays. (A) Quality analysis of islet RNA used in the
microarrays. Real-time PCR analysis comparing Ct values of equal cDNA amounts from islet or total pancreas RNA. Bars represent the islet/total
pancreas ratios of signals produced by specific oligonucleotides for amylase (grey bar), insulin 1 (black bar) or insulin 2 (clear bar), normalized to
beta-2-microglobulin (unchanged in all conditions). Ratios are presented in a log scale. (B) Graphical display of statistical analysis performed in
islet RNA from RasGrf1 KO microarray data compared to WT. The plot compares observed values against expected values in SAM-contrasting
analyses of six independent microarray hybridizations. Distance of a spot from the no-change diagonal means differential expression for a probeset
and it is measured by the d-value. Quantitative cutoff values and FDR parameters defined by the horizontal and diagonal dashed lines are specified in
the upper left corner. (C) Hierarchical clustering of the 4525 probesets showing differential expression in RasGrf1 KO islets (listed in Table S1, FDR 0.084;
threshold p-value: 0.046). Dendrogram was generated by cluster analysis of absolute expression values of probesets. Each row represents single
probeset expression. Columns identify results from single microarray hybridizations. Each box represents the hybridization signal value of a
probeset in the corresponding microarray assay. The intensity of color in each box provides a quantitative estimation of its expression change.
Blue: repressed probesets. Red: overexpressed probesets. Black: unchanged expression. Most significant KEGG pathways and associated p-values
for horizontal clusters: Clusters 1a and 1b: MAPK signaling (7.92E-4 and 2.3E-3 respectively) and Calcium signaling (1.9E-3 and 2.7E-3, respectively).
Cluster 1c: cytokine-cytokine interaction genes (p = 7.2E-4). Cluster 3: metabolic processes, including riboflavin metabolism and Kreb’s cycle (Cluster 3a,
p = 6.7E-4 and 1.6E-3) or pyruvate metabolism (Cluster 3b, p = 7E-3).
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functionally important in neural development and differ-
entiation, and Iapp (Islet Amyloid Polypeptide or amylin),
which is highly relevant for Beta cell functionality. Of
note, IAPP KO mice show increased insulin release and
glucose elimination responses, a behavior completely
opposed to that exhibited by our RasGrf1KO mice [40],
suggesting that Iapp downregulation in pancreatic islets
may be a compensatory mechanism triggered by the
absence of RasGrf1 in our KO mice. Interestingly, the
Gpdp3 gene is also found strongly repressed in the retina
of RasGrf1 KO mice [18], suggesting the occurrence ofcommon regulatory mechanisms for regulation of Gdpd3
expression by RasGrf1 in different cellular lineages or
environments.
It should be noted that one of the 3 probesets
(1435614_x_at) designed by Affymetrix to recognize the
RasGrf1 locus in the MOE 430A commercial microar-
rays used in this study produced a surprising result,
yielding significantly higher signals (about 4-fold) when
hybridized to RNA from the RasGrf1 KO islets than
after hybridization to their WT counterparts (Additional
file 1: Table S1, Additional file 2: Figure S1 panel A). Using
RT-PCR assays and specific primers we found out that this
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the specific genomic sequence recognized by this pro-
beset is localized within the 3-UTR untranslated region
of the RasGrf1 locus, a region that is not expressed in
the WT samples but appears overexpressed in our KO
mRNA samples, possibly as a result of neomycin-cassette-
dependent RNA polymerase activity associated to the spe-
cific construct vector used to generate our KO mouse
strain (Additional file 2: Figure S1, panels B, C) [17]. Con-
sistent with this, the LM5/LM85 pair of primers, designed
to recognize the catalytic domain of RasGrf1 (Additional
file 2: Figure S1 panel C; see Methods) produced signifi-
cant amplification of a specific 276 bp band in the WT
samples but not in the RasGrf1 KO samples (Additional
file 2: Figure S1, panel B). In contrast, primers MA1F/
MA2R, designed to hybridize exclusively at the very
end of the RasGrf1 3′ UTR region (Additional file 2:
Figure S1, panel C) yielded a 140 bp amplification
product only in KO islet samples, but not in the WT
samples (Additional file 2: Figure S1, panel B). On the
other hand, the combination of primers MA5F/MA2R,
designed to amplify a region corresponding to the last
two coding exons of RasGrf1 located downstream of the
coding sequence recognized by probeset 1422600_at and
upstream of the non-coding sequences recognized by pro-
beset 1435614_x_at and primer MA2R (Additional file 2:
Figure S1, panel C), amplified a 334 bp DNA fragment
only in the WT samples, but not in the KO samples,
showing that the mechanisms driving overexpression of
the 3′UTR in our KO samples did not involve expression
of the neighboring, coding RasGrf1 region.
Functional annotation and mechanistic implications of
the transcriptional signature of RasGrf1 KO pancreatic
islets. Alteration of components of Ras/MAPK and
Calcium signaling pathways
In order to try and unveil potentially relevant mechanistic
and functional clues related to the specific transcriptional
profile of RasGrf1 KO islet cells, we used functional an-
notation clustering software searching for co-occurrent
annotations pinpointing specific subgroups within the
list of differentially expressed genes identified in Table S1
(Additional file 1). Thus, separate analysis of the subsets
of induced and repressed loci listed in that Table using the
DAVID software package [41], identified a variety of GO
Biological Processes (Additional file 3: Table S2A and
Additional file 4: Table S2B) and KEGG Signaling Path-
ways (Additional file 5: Table S3A and Additional file 6:
Tables S3B) that could be ascribed with high statistical
significance (p-values < 0.05, ranging from E-17 to E-2)
to particular subgroups of repressed (Additional file 3:
Table S2A and Additional file 5: Table S3A) or induced
(Additional file 4: Table S2B and Additional file 6: Table
S3B) genes of the RasGrf1 KO islets.Figure 3 summarizes data from Tables S2A,B (Additional
files 3 and 4) and S3A,B (Additional files 5 and 6) by
quantitating the percentage distribution of the most
abundant subgroups of induced or repressed genes that
were functionally ascribable to various GO BP categor-
ies (Figure 3A) or KEGG pathways (Figure 3B) identified
by DAVID. As shown, the different GO BP Terms involv-
ing highest numbers of differentially expressed genes in
the RasGrf1 KO pancreatic islets (Figure 3A) include a
series of functional categories which are likely to be
relevant for the functionality, development and/or pro-
liferation of the specialized cell lineages composing the
pancreatic islets. Some of these categories (transcriptional
regulation, apoptosis) appeared to be more or less
equally affected by differential gene induction or repres-
sion (Figure 3A). In contrast, other functions, such as
cell proliferation or gland development, involved significant
higher numbers of downregulated genes than up-regulated
genes in the transcriptome of the RasGrf1 KO islets
(Figure 3A). Conversely, functional processes related to
protein transport, RNA splicing or protein metabolism
implied significantly higher numbers of up-regulated
genes than down-regulated genes in the transcriptome
of the KO islets (Figure 3A). The pattern of prevalent
downregulation of genes related to cell proliferation and
development appears to mirror the consistent defects of
beta cell development and proliferation previously de-
scribed in this RasGrf1 KO mice strain [17]. All in all,
these transcriptional alterations are consistent with a
significant functional role of RasGrf1 in control of de-
velopment and homeostasis of the specific cell lineages
present in pancreatic islets.
This notion is further supported by the DAVID-based
predictions of alterations in cellular (KEGG) signaling
pathways significant for islet functionality that are poten-
tially caused by the differential gene expression occurring
in the RasGrf1 KO islets (Figure 3B). In particular,
multiple components of the cross-talking MAPK sig-
naling pathways and Calcium signaling pathways were
very significantly affected by differential gene expression,
particularly by gene repression (p-values 1.0E-06 and
2,7E-06) in the RasGrf1 KO islets (Figure 3B, Additional
file 5: Table S3A). In addition, the Hedgehog (p-value 7,
5E-04) and WNT (p-value 9,4E-04) signaling pathways are
also predicted to be significantly downregulated in our
RasGrf1 KO islets (Figure 3B, Additional file 5: Table S3A)
and it is possible that the predominant downregulation of
the above mentioned pathways may also be related to the
repression of regulatory components of the actin cytoskel-
eton also observed (p-value 1,2E-02) in our RasGrf1 KO
islets (Figure 3B, Additional file 5: Table S3A). In contrast,
the components of signaling pathways relevant for
Ubiquitin mediated proteolysis (p-value 5.2E-06) and
Cell cycle regulation (p-value 1.3E-03) are predicted to
Figure 3 Functional annotation analysis of differentially expressed genes in pancreatic islets of RasGrf1 KO mice. The DAVID functional
annotation tool (http://david.abcc.ncifcrf.gov/) was used to identify statistically significant functional associations linking particular gene subsets
contained within the list of repressed (blue) or induced (red) loci occurring in RasGrf1 KO pancreatic islets (Additional file 1: Table S1, FDR = 0.084)
to specific Biological Process categories (Gene Ontology (GO) database, panel A) or Signaling Pathways (KEGG pathway database, panel B). Red:
Induction. Blue: repression. Percentage values were calculated by referring the number of genes in each individual subset to the total number of
repressed (1777) or induced (1943) genes recognized by DAVID within the list of differentially expressed genes listed in Table S1 (Additional file 1). The
complete functional annotation analyses are described in Tables S2A,B (search against Biological Process GO database) (Additional files 3 and 4) and
Tables S3A,B (search against KEGG signaling pathways database) (Additional files 5 and 6).
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pression in the RasGrf1 KO islets (Figure 3B, Additional
file 6: Table S3B). Interestingly most of the above men-
tioned cellular signaling pathways are known to be suscep-
tible of regulation by different Ras-dependent signals and,
specifically, RasGrf1 is a well-known mediator connecting
Calcium signaling and the Ras-MAPK pathway [1,11].
Focusing on individual repressed components of Ras/
MAPK signaling pathways it was striking to observe the
downregulation of multiple tyrosine kinase receptors
including EGFR, PDGFRA and B, and FGFR2 and 3, as
well as many of their specific ligands (including FGF2,
FGF3, FGF4, FGF17, FGF18, FGF21, FGF22, FGF23)(Additional file 5: Table S3A). Of note in this regard,
different studies have reported a positive paracrine/
autocrine effect of FGF to promote beta cell proliferation
and insulin secretion in pancreatic islets [42], with FGF21
in particular significantly improving pancreatic cell
function and beta cell survival through activation of
MAPK- and AKT- mediated signals [43]. It is therefore
likely that this downregulation of the FGF ligands and
receptors underlies the diminished number and smaller
size of pancreatic islets observed in the pancreas of
RasGrf1 KO mice [17]. Regarding MAPK signaling, it was
also striking to observe the downregulation of several
GEFs, such as RasGrf2, Sos1, RasGRP1 and RasGRP2,
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members in different cellular contexts. While the absence
of Ras-GEF activity may also be related to the defective
functionality of beta cells in pancreatic islets of RasGrf1
KO mice, these observations also confirm the absence of
compensatory transcriptional activation of other GEFs
associated to the disappearance of RasGrf1 in those cells
[17]. On the other hand, the possibility of mechanisms
aimed at compensating at other levels the defective Ras-
mediated signaling of RasGrf1 KO islet cells, might be
consistent with the observed overexpression of different
GTPase family members including Kras, Rac1, Gna1 and
multiple Rab family members, as well as potential regula-
tors and effectors thereof.
Calcium metabolism is crucial for proper islet metabol-
ism [44], and the changes of expression in several import-
ant components in the regulation of calcium metabolism in
RasGrf1 KO Langerhans islets suggest a link with the
metabolic alterations previously described by our labora-
tory [17]. In this regard, it was also particularly striking the
observed repression of up to 8 different calcium channels,
including CACNG8, CACNG7, CACNG6, CACNG2,
CACNB1, CACNA1S, CACNA2D2, CACNA1F in RasGrf1
KO islets (Additional file 5: Table S3A).
Finally, it was also very noticeable the dysregulation of
the expression of multiple upstream components of the
cascade of kinases involved in Ras/MAPK signaling
pathways (including several isoforms of protein kinase
C isoforms, as well as several MAPK cascade isoforms
(reduced expression of Mapk13, Map2k2, Map2k7,
Map3k7, Map3k8 and Map4k1, as well as overexpression
of Mapk1, Mapk8, Mapp2k1, Map3k3, Map3k4 and
Map4k3) (Additional file 1: Table S1, Additional file 5:
Table S3A and Additional file 6: Table S3B). As an import-
ant number of the mitogen activated protein kinases have
been related to JNK-dependent pathways [45], it is pos-
sible that this dysregulation may be related to cellular
stress caused by the absence of RasGrf1 to the beta cells
of our RasGrf1 KO mice.
The expression of various phosphatases participating in
Ras/MAPK signaling pathways was also found dysregulated
in the RasGrf1 KO islets (Additional file 5: Table S3A and
Additional file 6: Table S3B). Thus, whereas most differen-
tially expressed Ptpn isoforms were down-regulated, about
half of the differentially expressed members of the Dusp
family (dual specificity phosphatases acting on phosphory-
lated MAPK forms) were down-regulated, and the other
half were up-regulated in RasGrf1 KO islets (Additional
file 1: Table S1, Additional file 5: Table S3A and Additional
file 6: Table S3B). All differentially expressed isoforms
of the Ppm magnesium-dependent phosphatases were
overexpressed in KO islets. On the other hand, whereas
the calcineurin isoform Ppp3cc was downregulated, the
isoforms Ppp3r1 and Ppp3ca were overexpressed in theRasGrf1 deficient islets (Additional file 1: Table S1,
Additional file 5: Table S3A and Additional file 6:
Table S3B). Calcineurin activity is likely to be relevant
for pancreatic islet functionality as it has been reported to
dephosphorylate and control localization and activity of
NFAT transcription factors in pancreatic beta cells [46].
The transcriptional profile of phospholipase downstream
effectors of Ras/MAPK signaling is also found significantly
altered in the RasGrf1 KO islets (Additional file 1: Table S1,
Additional file 5: Table S3A and Additional file 6: Table
S3B). Interestingly, PLA2G6 has been reported to protect
beta cells from apoptosis via the generation of arachidonic
acid and prostaglandin E2 [47] and the repair of mito-
chondrial membrane peroxidation [48] as well as modu-
lating oscillations and transients of [Ca+2]i in response to
ATP in these cells [49]. Accordingly, overexpression of
PLA2G6 in the islets of our RasGrf1 KO mice would be
consistent with our previous phenotypic characterization
of reduced proliferation and unchanged apoptotic rates in
beta cells of those animals [17].
Finally, several transcription factors known to act in
Ras/MAPK signaling pathways were also significantly
affected by differential gene expression in the RasGrf1
KO islets. In particular, ATF2, DDIT3, ETS1 and JUND
[50-53] were up-regulated, whereas Elk1, RORA, USF,
NFATC2 and NFATC4 [46,52,54-56] were significantly
repressed (Additional file 1: Table S1, Additional file 5:
Table S3A and Additional file 6: Table S3B). As NFAT/
calcineurin signaling interactions (with calcineurin ac-
tivating cytoplasmic NFAT by dephosphorylation) are
very important for regulation of pancreatic beta-cell
growth and function [46], the observed differential ex-
pression of several NFAT and calcineurin isoforms also
points to significant alteration of related Ras/MAPK
signals in our Ras defective KO islets.
In summary, all these functional implications and mech-
anistic predictions derived from analysis of the transcrip-
tional patterns in pancreatic islets of RasGrf1 KO animals
are indicative of alterations of Ras/MAPK signaling path-
ways and Calcium signaling, and are consistent with our
previous characterization of pancreatic beta cell signaling
phenotypes and preliminary, direct measurements of
reduced ERK responses and Ca++ movements in isolated
islets preparations of these KO mice [17].
Inferred regulatory mechanisms responsible for differential
gene expression in RasGrf1 KO islets. Potential role of Pttg1
Most genes showing differential expression in the RasGrf1
KO islets (Additional file 1: Table S1) appeared to undergo
specific transcriptional modulation of their expression at
this precise location by RasGrf1, since a comparison of the
microarray-based transcriptional profile of RasGrf1 KO
islets (Additional file 1: Table S1) with those previously
described at other tissue locations of the same RasGrf1
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pyramidal cells, and brain olfactory bulb, cerebral cortex
or full hippocampus) [18,32] documented the occurrence
of specific transcriptional patterns at each of those tissue
locations. Interestingly however, a limited number of tran-
scripts showed consistently common patterns of differen-
tial expression (induction or repression) at two or more of
those different tissue locations in our RasGrf1 KO mice
(Additional file 7: Table S4). The fact that all those tissues
share a common neuroectodermal origin suggests the
possibility that the members of this gene group are paral-
lely regulated loci playing a preferential, primary driver
role in the mechanisms controlling the establishment of
the overall mRNA expression profile associated with the
absence of RasGrf1 expression in those tissues.
Remarkably, of all loci listed in Table S4 (Additional
file 7), only Pttg1 showed the same pattern of transcrip-
tional alteration (significant repression) in all different
tissues analyzed in our RasGrf1 KO mice (Additional file
7: Table S4) [18,32]. The repression of the Pttg1 locus at
the transcriptional level was also confirmed at the level
of protein expression by means of WB assays (Figure 4)
which also confirmed and validated the patterns of
microarray-based differential expression identified in pan-
creatic islets for several other randomly selected, repressed
or induced loci listed in Table S1 (Additional file 1). The
consistent pattern of Pttg1 repression observed in the var-
iety of tissues mentioned above, suggests the existence of
common, shared RasGrf1-sensitive mechanisms of tran-
scriptional regulation of the Pttg1 locus in all those neu-
roectodermal tissue locations. The remarkable phenotypic
similarities exhibited by Pttg1 KO mice and our RasGrf1
KO mice are also consistent with this notion, and support
the possibility of proximal functional or regulatory inter-
actions between RasGrf1 and Pttg1 [17,31]. Although not
all their phenotypes are exactly identical (qualitatively or
quantitatively), the strong phenotypic similarities observed
in both KO mice models (including lower body weight,
hypoinsulinemia and altered responses to glucose and
insulin responses) strongly suggest the possibility of
interconnected regulatory mechanisms controlling expres-
sion of RasGrf1 and Pttg1 and/or functional proximity
between these two proteins in signaling pathways of the
pancreatic islets.
On the other hand, knockout mice for Iapp, another
highly repressed locus in pancreatic islets (Additional file 1:
Table S1), show increased insulin and glucose responses
[40], a behavior completely opposed to that exhibited by
our RasGrf1 KO mice [17,40], suggesting the possibility
that Iapp down-regulation might be a compensatory
mechanism triggered by the absence of RasGrf1 in pan-
creatic islets and pointing to the possible existence of a
wider, RasGrf1-dependent regulatory network involving
transcriptional regulatory interactions modulating moregenes than just Pttg1. This may be the case for the Crb1
(Crumbs homolog 1) locus in view of the observation of
significant transcriptional repression of this locus in the
retina [18] of RasGrf1 KO mice and its simultaneous over-
expression in the islets of the same animals (Additional
file 7: Table S4) and the previous report in an animal
model of Retinitis Pigmentosa, where a point mutation in
CRB1 that causes retinal degeneration, is linked to a
strong reduction in the expression of Pttg1 [57]. The ex-
istence of a wider network of transcriptional regulation
dependent upon the expression of RasGrf1 in various
neouroectodermal cellular lineages or environments, is
also consistent with the transcriptional behavior of two
other loci – Aldh7a1 and Gdpbp3 – which are found
simultaneously repressed in retinas and islets (Additional
file 1: Table S1 and Additional file 7: Table S4), [18] of our
RasGrf1 KO mice.
Based on the highly consistent repression of Pttg1
detected in all neouroectodermal tissues analyzed in
our RasGrf1 KO mice (although other genes may display
quantitatively higher levels of repression in pancreatic is-
lets), in order to gain further mechanistic insights under-
lying the transcriptional observations mentioned above,
we decided to carry out more-in-depth analyses of mo-
lecular or functional interactions between RasGrf1 and
Pttg1 using (i) specific cell lines expressing these signaling
molecules or (ii) KO animals devoid of their expression,
either singly or in a combination.
To start our search for potential mechanisms behind the
regulation of Pttg1 expression by RasGrf1, we initially used
TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.
html; [58] looking for Transcription Factors with consensus
recognition sequences locatable within the mouse Pttg1
promoter region (Table 1). Furthermore, we also applied
GeneCodis gene set enrichment analysis [59] software
to identify TFs potentially responsible for the patterns
of repressed (Additional file 8: Table S5A) or induced
(Additional file 9: Tables S5B) genes identified by means
of microarrays (Additional file 1: Table S1) in our RasGrf1
KO islets.
Interestingly, comparison of Table 1 and S5 (Additional
file 8) uncovered very significant coincidences, as many
TF from Table 1 were also identified by GeneCodis as
potentially responsible for differential expression of re-
pressed or induced subsets of the transcriptome of KO
islets (Additional file 8: Table S5A and Additional file 9:
Table S5B). Specifically, GeneCodis analysis of the pool
of downregulated loci in pancreatic islets of RasGrf1
KO mice identified several distinct groups of repressed
genes (Additional file 8: Table S5A) that are known tar-
gets for transcriptional regulation by TF such as E12,
LEF1, MAZ, SP1, NFAT and AP4 at exceptionally high
levels of statistical significance (Additional file 8: Table
S5A). In addition, several other subsets of repressed loci
Figure 4 Protein expression changes in pancreatic islets of
RasGrf1 KO mice. Western immunoblot and Immunohystochemistry
assays confirming and validating several transcriptional alterations
previously detected by means of microarray analysis in pancreatic islets
from RasGrf1 KO mice. (A) Representative ECL exposures of WB assays
performed in protein extracts of WT and KO pancreatic islets, using
specific antibodies against IAPP, PDFR, FGFR, TXNL or PTTG1.
Unchanged Ras and beta-tubulin signals are shown as internal loading
controls. (B) Representative immunohystochemical staining of WT and
KO pancreatic sections showing increased expression levels of the
GRIA2 and PHTF1 proteins in pancreatic islets of RasGrf1 KO mice (islets
outlined in yellow). (C) Normalized PTTG1 to Beta-tubulin signal ratios
in Western blots of WT and KO islets quantitated using the image-J
software program. For comparison purposes, this ratio was set to 1 in
WT samples.
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FOXO4, PAX4, ETS2 or AP1 transcription factors at
high levels of significance (p-values <1E-30 in all cases;
Additional file 8: Table S5A). Similar GeneCodis analysis
also identified, at very high levels of statistical significance
(P-values <1E-24 in all cases), a number of distinct subsets
of induced, overexpressed genes of the transcriptome of
RasGrf1 KO islets that are recognized transcriptional
targets of TF such as SP1, LEF1, MAZ, ELK1, E4F1,
GABP, FOXO4, YY1, MYC, NFY or NFAT (Additional
file 9: Table S5B). Furthermore, consistent with a sug-
gested pattern of positive and negative transcriptional
regulation, the actual mRNA levels quantitated with
microarrays (Additional file 1: Table S1) for several of
the transcription factors listed in Table 1 were indeed
significantly amplified (ETS1, HNF4a, MEF2a, NKX2-2)
or reduced (HNF4g, MEF2b, RORalp, SRY) in the tran-
scriptome of pancreatic islets devoid of RasGrf1 protein
(respective R-fold and D-values in Additional file 1:
Table S1).
Of note, whereas many TFs with sequence recognition
sites recognizable in the Pttg1 promoter region (Table 1)
are known to be functionally linked to Ras-MAPK signal-
ing pathways (Brn2, Cebp, COUP-t, CRE-BP, Elk1,ETS,
E2F, E4BP4,GATA-1, -2 & -3, HNF3b, MEF-2, Nkx-2,
NRF2, Oct1, RORA, Sp1, USF and YY1) [55,60-68]. In
addition, most of them (C/EBP, E2F, E4BP4, Elk-1, ETS,
GATA-3, HNF3B(=FOXA2), HNF4, NKX2, NRF2, Oct1,
Sp1, USF and YY1) have also been described in the litera-
ture to play, significant functional roles in pancreatic and
beta cell physiology [27,53,69-79]. Thus, a potential mech-
anistic link between Pttg1 and the altered, differential gene
expression linked to Ras-MAPK signaling in RasGrf1 KO
islets is suggested by the observation that several of the
TF related to Ras-MAPK signaling and listed in Table 1
because of the presence of sequence recognition sites
in the promoter region of Pttg1 (i.e., ETS1, E2F5,
E2F6), are also differentially expressed in the RasGrf1 KO
islets (Additional file 1: Table S1). Likewise, a similar
Table 1 Transcription factors with recognition binding sites located in the mPttg1 promoter
AML-1a E2F (E2F5*, E2F6*) HSF2 RORa
Brn-2 E4BP4 Ik-2 S8
CdxA Elk-1 Ik-3 Sox-5
C/EBP Evi-1 Lyf-1 Sp1
C/EBPb GATA-1 MEF-2 (MEF2a*, MEF2b, MEF2c* and MEF2d) SRY
c-Ets (ETS1* and ETS2) GATA-2 MZF1 TATA
COUP-T GATA-3 Nkx-2 (NKX2-2*, NKX2-3, NKX2-4, NKX2-5, NKX2-6) USF
CP2 HFH-1 NRF-2 v-Myb
CRE-BP HNF-3b Oct-1 YY1
deltaE HNF-4 (HNF4a* and HNF4g) Pbx-1
Analysis of the relationship of transcription factors capable of binding to the Pttg1 promoter with their differential gene expression in RasGrf1 KO pancreatic islets.
List of 39 transcription factors (TF) with potential binding sites locatable in the promoter region of the mPttg1 locus as determined by TFSEARCH (http://www.
cbrc.jp/research/db/TFSEARCH.html) analysis of a 2,3 kbp region located 5′upstream of the transcription initiation site. TFs coincident with those identified by
GeneCodis analysis as potentially responsible for the transcriptional profile of repressed (Additional file 8: Table S5A) or induced (Additional file 9: Table S5B)
genes in the transcriptome of RasGrf1KO islets (Additional file 1: Table S1) are marked in bold. TFs whose expression is altered in the transcriptome of RasGrf1 KO
islets (Additional file 1: Table S1) are marked with asterisks (overexpressed) or shown in italics (repressed).
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ential gene expression in pancreatic islets of RasGrf1
KO mice, as several of the main transcription factors
and regulatory gene networks and interactions in-
volved in pancreatic islet development and Beta cell
function [46,74,80] present sequence recognition sites
in the promoter region of Pttg1 (i.e., Hnf3b (=FoxA2),
Hnf4a and NKx2-2, Table 1) and/or are also differentially
expressed in the RasGrf1 KO islets (Additional file 1:
Table S1). It is highly striking to observe that most of
these TF and regulatory genes, which are likely to be
functionally relevant for Ras-MAPK signaling and/or
beta cell function, are overexpressed (Additional file 1:
Table S1). This observation suggests the interesting hy-
pothesis that their overexpression (in particular, Hnf3b
(=FoxA2), Hnf4a and NKx2-2) may represent a compen-
satory mechanism elicited in the developing pancreas in
order to counterbalance the reduced number/size of the
islets, and the hypoinsulinemia and reduced proliferation
of beta cells exhibited by the RasGrf1 KO mice [17].
In any event, to uncover potential functional interac-
tions between RasGrf1 and Pttg1 and in order to ascertain
the involvement in those processes of Ras-ERK or other
signaling pathways dependent upon RasGrf1, we aimed
to study by means of reporter constructs the effect of
RasGrf1 overexpression on Pttg1 promoter.
RasGrf1 modulation of Pttg1 promoter activity through
cytosolic kinase-mediated signaling
In order to ascertain whether or not RasGrf1 exerts any
type of direct or indirect control over Pttg1 expression,
we carried out luciferase assays analyzing the effect of
different RasGrf1 expression levels as well as various
agonist and inhibitors of RasGrf1-dependent signaling
pathways in BTC3 cells transfected with a reporterconstruct containing a 2.3 Kb fragment of the mPttg1
5′untranslated region [81] (Figure 5). We chose this
cell line as particularly appropriate for this kind of
studies as it is known to express RasGrf1 in basal condi-
tions and is also derived from an insulinoma [82], thus
providing a cellular environment that is physiologically
similar to the pancreatic beta cells of our animals.
We observed that RasGrf1 overexpression achieved
through transfection of a RasGrf1 construct in these
cells (Figure 5C) resulted in significant increase (about
30%) of the mPttg1 promoter activity both under basal,
unstimulated conditions or after stimulation with various
agonists known for their ability to activate RasGrf1-
dependent signaling, (particularly ionomycin and LPA) [1]
(Figure 5A). Interestingly, no significant changes could be
detected when similar reporter assays were performed in
other cell lines of different embryological origin which did
not express RasGrf1 under basal conditions, such Cos1
or 293 T (data not shown), supporting the notion that the
detected expression relationship between RasGrf1 and
Pttg1 suggested by our microarray studies (Additional
file 1: Table S1 and Additional file 7: Table S4) may be
linked to this particular cellular environment of pancre-
atic cells.
We also tested the effect of inhibitors of various cytosolic
kinases in our reporter assays of transcriptional activity
dependent upon the mPttg1 promoter region in BTC3 cells
(Figure 5B). Interestingly, of all inhibitors used, only the
MEK1/2 inhibitor U0126 significantly reduced (about 50%)
the transcriptional activity of the Pttg1 promoter when
compared to untreated controls, whereas no significant
changes were detected in the assays involving PI3K
(wortmannin) or JNK (SP600125) inhibitors (Figure 5B).
It was apparent that the MEK1/2 inhibitor did not block
completely the Pttg1 promoter activity and therefore
Figure 5 Effect of RasGrf1 on mPttg1 promoter activity. Luciferase reporter assays carried out in insulinoma BTC3 cells cotransfected with
plasmid pGL3 (containing a 2,3 Kb promoter region of mPttg1) plus one additional construct, corresponding either to empty plasmid vector
pBKCMV (black boxes) or to construct pBKCMV-RasGrf1, expressing a full length RasGrf1 cDNA clone (white boxes). (A, B) Assays were performed
48 hours after cotransfection and included treatment for 7 hours with the indicated agonists (panel A) or inhibitors (panel B) of signaling
pathways, under conditions detailed in Methods. (C) Western immunoblot showing level of overexpression of the RasGrf1 full length protein in
BT3 cells after 48 h transfection with pBKCMV-RasGrf1. Error bars indicate coefficient of variation. * p < 0.05; ** p < 0.01; n = 3 for Vector and
RasGrf1 samples. Dotted lines: comparison between RasGrf1 overexpression and transfection with the control vector. Solid black lines: comparison
between treated and non treated cells.
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for the relation between RasGrf1 and the Pttg1 promoter.
However, we also observed that the reduction of Pttg1
promoter activity caused by MEK1/2 blockade was signifi-
cantly higher (almost double) in RasGrf1-overexpressing
cells than in the cells transfected with vector alone
(Figure 5B) and that MEK2 expression was significantly
repressed in RasGrf1 KO islets (about 40%, see Additional
file 1: Table S1). These observations suggest that, although
other pathways may be involved, there is at least a partialcontribution of RasGrf1-ERK signaling to the control of
Pttg1 promoter activity in these cells and are consistent
with a previous report associating partial repression of
PTTG1/Securin gene expression to the inhibition of the
Ras/Raf/ERK pathway in HCT116 cells [83].
Altogether, our previous microarray expression data
(Additional file 7: Table S4) together with these reporter
assays (Figure 5) suggest that neuroectodermic, RasGrf1-
expressing, pancreatic islet β-cells determine a specific
transcriptional microenvironment that includes specific
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expression by RasGrf1. Furthermore, our demonstration
that the modulation of Pttg1 expression by RasGrf1 is
mediated by ERK signaling in pancreatic cells is also
consistent with previous similar observations in other
cell types, such as the MCF7 and U87 breast cancer cell
lines [84,85].
Phenotypic interplay between RasGrf1 and Pttg1 in
RasGrf1/Pttg1 double knockout mice
In view of the above results and the phenotypic similarities
exhibited by single RasGrf1 or Pttg1 KO mice, we wished
to further explore any potential functional overlapping or
interactions occurring between RasGrf1 and Pttg1 in the
endocrine pancreas. For this purpose, we crossed our
RasGrf1 KO mice [17] with Pttg1 null animals originated
in S. Melmed’s lab [86]. WT and double knockout (DKO)
mice arising from these crosses were interbred for several
generations to produce a homogeneous genetic background
allowing meaningful functional comparisons between the
different genotypes.
Our initial analysis of the DKO RasGrf1/Pttg1 mice
generated (Figure 6A) documented that they were viable
and fertile, and did not show any gross phenotypic differ-
ences in comparison to their single KO parental ancestors.
In particular, their birth rates, lifespan and body weight were
rather similar to those of single RasGrf1 or Pttg1 KO mice
[86]. Interestingly, we observed that the body mass of the
RasGrf1-Pttg1 DKO mice was significantly reduced (about
60-70%) in both males and females at 3 and 10 months of
age (Figure 6B and data not shown) as compared with
their WT controls, but this reduction was quantitatively
similar, and not stronger than that already previouslyFigure 6 Characterization of double knockout (DKO) RasGrf1/
Pttg1 mice. (A) Diagnostic PCR genotyping analyses of the RasGrf1
and Pttg1 loci in genomic DNA extracted from the tail of WT and
double knockout (DKO) RasGrf1-Pttg1 mice. (B) Bar charts comparing
the body weights of 3-month-old and 10-month-old WT and DKO
RasGrf1-Pttg1 mice. Error bars indicate SD. * p < 0.05. ***; p < 0.001;
n = 10 for WT; n = 13 for DKO.described for individual RasGrf1 and Pttg1 KO mice
[17,86]. The observation that the simultaneous dis-
appearance of RasGrf1 and Pttg1 did not cause any
additive or synergistic effects over the reduction of body
mass previously described in the individual RasGrf1 or
Pttg1 KO mice may be consistent with the functional par-
ticipation of these two proteins at different levels of the
same cellular signaling pathways involved in controlling
these body growth aspects. On the other hand, not all
phenotypic aspects previously described for RasGrf1 or
Pttg1 KO are shared. Thus, In spite of the association pre-
viously described between RasGrf1 and Pttg1 in the mice
retina [16,26,86], no photoreception defects were observed
in our single Pttg1 KO animals (data not shown).
As some of the main phenotypic traits shared between
single KO mice for the RasGrf1 and Pttg1 loci included
reduced body weight, hypoinsulinemia and defective β-cell
development and glucose tolerance responses [18], we also
aimed at analyzing how the combination of both KO line-
ages affected these parameters in DKO animals, in order
to further characterize potential functional interactions
between RasGrf1 and Pttg1 in the cells of pancreatic islets.
In particular, as a reduced number of pancreatic islets was
previously reported in single RasGrf1 or Pttg1 KO animals
when compared to their control counterparts [17,31],
we wished to evaluate the effect of the simultaneous
disruption of both proteins on both the number and
size of pancreatic islets and their content of alpha and
beta cells in DKO mice. Our analysis of collagenase-
digested pancreases of 8 month-old animals of the four
different genotypes on the same genetic background
(Figure 7) showed that single RasGrf1 KO mice exhibited
about 50% reduction in the islet number per organ in
comparison to the WT controls, whereas the single Pttg1
KO showed a dramatically higher reduction (about 90%)
and the DKO RasGrf1/Pttg1 did not show statistically
significant quantitative differences of such islet count in
comparison to the single Pttg1 KO mice (Figure 7A,B).
In addition, specific immunostaining of the islets for
glucagon-producing alpha cells and insulin-secreting beta
cells documented that the observed reduction of the
pancreatic islet pool in DKO mice was much more sig-
nificantly linked to a reduction of the beta cell com-
partment than the alpha cell compartment in the
pancreatic islets of DKO mice devoid of both RasGrf1 and
Pttg1 (Figure 7C, D). These observations are consistent
with, and confirm previous reports documenting a signifi-
cant reduction of beta cell counts in the single KO
RasGrf1 or Pttg1 KO mice [17,31].
Although we have previously identified RasGrf1 as an
important mediator of beta cell development and prolifer-
ation [17,31], the much more drastic –decisive– quantita-
tive effect of the absence of Pttg1 (about 90% inhibition)
than RasGrf1 (about 50% inhibition) on development of
Figure 7 Quantitation of pancreatic islets and related cell
lineages in RasGrf1 and Pttg1 KO mice. (A). Total pancreatic islet
count in 8 month-old animals of the indicated genotypes. Count
was performed under a dissecting microscope analyzing collagenase
digests of total pancreas from WT, single KO and double KO mice
at 8 months of age. Error bars indicate SD. * p < 0.05; ** p < 0.01;
*** p < 0.005; n = 10 for WT; n = 11 for RasGrf1 KO; n = 6 for Pttg1
KO and n = 4 for RasGrf1/Pttg1 DKO. (B). Specific immunostaining
of alpha (red) and beta (green) cells in pancreatic islets of WT and
RasGrf1/Pttg1 DKO mice. Inmmunofluorescent staining for insulin
(green) and glucagon (red) producing cells in paraformaldehyde-fixed
pancreatic sections from WT and DKO mice (400 X). (C). Normalized
numbers of alpha and beta cells in pancreatic islets of WT and
RasGrf1/Pttg1 DKO mice. Numbers of alpha or beta cells per
individual islet, as well as beta/alpha ratio in total pancreas are
represented. The data documents a significantly higher reduction
of the beta cell compartment in the DKO mice. Error bars indicate
SD. * p < 0.05; ** p < 0.01; *** p < 0.005; n = 3.
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proximity of Pttg1 over RasGrf1 to the actual downstream
mechanistic components of signaling pathways that con-
trol beta cell development and proliferation. This notion
of RasGrf1 and Pttg1 participating in the same signaling
pathways, but RasGrf1 acting more distally than Pttg1
to the final effectors of those pathways that are directly
responsible for beta cell development would also be
consistent with our previous observations that the
RasGrf1 KO mice display a specific reduction of about50% of Pttg1 expression (Additional file 1: Table S1,
Figure 4), as opposed to the total absence of Pttg1 oc-
curring in the Pttg1 KO mice.
The preeminence of Pttg1 over RasGrf1 regarding the
generation of the above mentioned islet- and beta cell-
related phenotypes is also supported by the results of our
assays of insulin release response and glucose tolerance
tests carried out after administration of a bolus of glucose
to the DKO mice (Figure 8). Indeed, analysis of serum in-
sulin in our KO animals confirmed that both the single
RasGrf1 and Pttg1 KO mice exhibited lower levels of
serum insulin than their WT counterparts [17,86], but the
levels of individual Pttg1 KO mice were already very low
and similar to those of the DKO mice and certainly lower
than those of single RasGrf1 KO mice (Figure 8A-D). Par-
allel GTT assays (not shown) were also consistent with
the insulin release assays, but did not show statistically
significant differences between the behavior of the DKO
mice in comparison to the previously described behavior
of the individual KO for RasGrf1 and Pttg1.
Altogether, our results suggest that Pttg1 is an import-
ant signaling molecule acting downstream of RasGrf1 in
signal transduction pathways relevant for control of beta
cell development and physiological responses dependent
upon pancreatic islet function.
Conclusions
Besides defective memory/learning and impaired eye
vision abilities, RasGrf1 KO mice also exhibit a reduced
body size linked to a “pancreatic” phenotype that includes
significantly reduced number and size of pancreatic islets,
diminished beta cell proliferation and neogenesis, and
associated hypoinsulinemia and glucose intolerance,
suggesting an essential role of RasGrf1 in beta cell de-
velopment and function.
The remarkable similarities existing among the “pancre-
atic” phenotypes of our RasGrf1 KO mice and those inde-
pendently described for Cdk4 KO mice , p70S6K KO mice
or Pttg1 KO mice, suggest the possibility that RasGrf1
and the other three different signaling molecules may
contribute functionally at different levels of the same
Ras-dependent signaling pathways acting in the islet cell
lineages regulating pancreatic endocrine functions.
In order to try and ascertain the functional role of
RasGrf1 in pancreatic islet and beta cell function, here we
used commercial microarrays to characterize the specific
transcriptional profile caused by the disappearance of
RasGrf1 from the pancreatic islets of our RasGrf1 KO
mice. Our data uncovered differential expression of
multiple genes coding for components/regulators of
MAPK- and calcium-signaling pathways in pancreatic
islets, suggesting a relevant contribution of RasGrf1 to
the control of endocrine functions of the different cell
lineages present in pancreatic islets.
Figure 8 Glucose tolerance tests in WT and single or DKO mice for the RasGrf1 and Pttg1 loci. Male animals of the indicated ages and
genotypes were fasted for 16 h and then injected intraperitoneally with a bolus of 2 mg glucose/g body weight. Serum levels of insulin were
measured by ELISA after blood extraction at the times indicated. (A) Blood insulin in 3 month-old RasGrf1/Pttg1 DKO animals basal (0 min) and
upon glucose injection. (B) Blood insulin induced by glucose injection in 10 month-old DKO mice. (C) Insulin levels in RasGrf1 KO mice at
10 months of age upon glucose injection. (D) Insulin levels in Pttg1 KO animals at 10 months upon intraperitoneal glucose injection. Error bars
indicate SD. * p < 0.05; n = 7 for 3 month-old WT; n = 12 for 3 month-old DKO; n = 6 for 10 month-old WT; n = 12 for 10 month-old DKO; n = 6 for
single RasGrf1 KO and n = 4 for their WT controls; n = 3 for single Pttg1 KO mice and n = 5 for their WT controls.
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significantly different from that of other neuroectodermal
tissues (i.e., retina, olfactory bulb, cerebral cortex, or
hippocampus) isolated from the same RasGrf1 KO
mice but, remarkably, shared with all of them a com-
mon alteration involving the significant transcriptional
repression of the Pttg1 locus.
Interestingly, analysis of the promoter region of mPttg1
identified specific recognition sites for numerous Tran-
scription Factors which were also differentially expressed
in the RasGrf1 KO pancreatic islets and are also known to
be relevant for Ras-MAPK signaling as well as for pancre-
atic islet development and beta cell function. In addition,
reporter luciferase assays in transfected BTC3 insulinoma
cells overexpressing RasGrf1 documented the ability of
RasGrf1 to modulate Pttg1 promoter activity through
ERK-dependent signals. Furthermore, characterization
of RasGrf1/Pttg1 double KO mice generated in our
laboratory showed that the combined knockout of both
loci caused pancreatic phenotypic alterations which were
quantitatively close to those of single Pttg1 KO mice andmuch more prominent than those measured in single
RasGrf1 KO mice.
Our data supports the existence of close functional
and regulatory links between RasGrf1 and Pttg1 in the
cell lineages of pancreatic islets, where RasGrf1 appears
to be a critical signaling component acting upstream of
Pttg1 in pathways controlling beta cell development and
function.
Methods
Purification of pancreatic islets RNA isolation and RT-PCR
analysis
3-Month-old male C57BL/6 N wild type and RasGrf1
KO mice were sacrificed and their pancreases carefully
digested with collagenase P (Roche, Switzerland). Pancre-
atic islets were handpicked under a stereo microscope,
counted and subsequently washed with HBSS buffer
(Invitrogen, CA, USA) as previously described [87]. Is-
lets isolated from three separate animals of the same
genotype (wild type or RasGrf1 KO) were pooled in
order to obtain sufficient amounts of RNA for analysis
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eighteen individual animals (9 WT and 9 KO) were used
to generate the samples analyzed in this study.
Total RNA from either islets or total pancreas was then
extracted as previously described [88]. Quantification and
quality of total RNA was determined using RNA 6000
nanochips (Agilent Technologies, CA, USA). RNA sample
purity from isolated pancreatic islets was estimated by
comparing it with RNA extracted from total pancreas. For
this purpose the Ct values of total pancreas RNA was
compared to that of isolated islet RNA as previously
described [35]. Quantitative real-time PCR analysis was
made by measuring insulin and amylase expression using
beta-2 microglobulin (B2MG) as internal control. The en-
richment of the islets’ RNA was calculated using the ratio
(islet insulin/pancreatic insulin)/(islet amylase/pancreatic







For RasGrf1 expression analysis, 3 μg islet RNA ex-
tracted from wild type or RasGrf1 KO islets were
reverse-transcribed at 50°C for 1 h with RT-PCR kit
according to manufacturer instructions (Invitrogen, CA,
USA). 1/10 islet cDNA was used in subsequent PCR reac-
tions. The oligonucleotides against RasGrf1 used in the







Microarray hybridization and data analysis
Labeled cRNA was obtained according to a protocol
previously described [89]. Biotinylated cRNA from three
different wild type samples and three RasGrf1 KO samples
(each being an RNA pool obtained from three different
animals of the relevant genotype), were checked for
quality in Test3 arrays, before hybridization to MOE430A
oligonucleotide arrays, containing 22690 oligonucleotide
probe sets, corresponding to about 20000 mice genes
(Affymetrix, CA, USA). Stained microarrays were scanned
in a GeneArray Scanner (Hewlett Packard, CA, USA). All
in all, data from 6 separate microarray hybridizations were
analyzed in this study.
Using Bioconductor and R as computational tools
(www.bioconductor.org), the RMA (Robust Microarray
Analysis) algorithm [36] was applied for background
correction and normalization of fluorescent hybridizationsignals as previously described [89]. Thus, we obtained
quantization of expression level of probe sets in each
microarray. SAM (Significance Analysis of Microarrays)
algorithm [37] was used to identify probe sets displaying
significant differential expression when comparing the KO
samples to their respective controls using the calculation
of the FDR (False Discovery Rate) parameter [90]. The
matrix of expression values for all microarray hybridiza-
tions performed was analyzed using the hclust clustering
algorithm implemented in R [91]. DAVID bioinformatics
resources consist of an integrated biological knowledge-
base and analytic tools aimed at systematically extracting
biological meaning from large gene/protein lists [41]. Data
analysis in this software used the EASE score, a modified
(more stringent) Fisher exact p-value, as statistical filter
[92]. As DAVID, Genecodis algorithm allows finding re-
lationships among annotations based on co-occurrence
patterns (http:/genecodis.dacya.ucm.es/; [59]. For tran-
scription factor annotations it uses mouse TR list con-
tained in the GSEA database [93], which are derived
from a previous work by Xie and co-workers [94].
Western blotting, immunoprecipitations and
immunostaining
For immunobloting, manually isolated islets from 3 month-
old male mice were homogenized in 100 μl RIPA buffer
and separated in SDS-PAGE gels as previously described
[32]. The gels were then transferred to nitrocellulose mem-
branes using a semi-dry iBlot® system (Invitrogen). Finally,
membranes were blocked in 2% BSA in TBS-T (20 mM
Tris/HCl (pH 7.5), 150 mM NaCl and Tween-20 al 0.05%)
from 30’ to 2 hours. Next step was incubation with the
primary antibody of interest in 2% BSA in TBS-T at 4°C
overnight or 2 hours at RT. We used anti-Pttg1 1:1000
(Immunostep); anti-RasGrf1/2 1:1000 (sc-224 Santa Cruz
Inc, CA, USA); anti-PDGFR 1:500 (sc-338 Santa Cruz
Inc, CA, USA); anti-FGFR3 1:500 (sc-123 Santa Cruz Inc,
CA, USA);, anti-TXNL 1:200 (A22165A, Genway Biotech
Inc. San Diego, CA, USA); anti-Ras (Ras M90 monoclonal
antibody [95] and β-tubulin 1:5000 (Sigma).
For immunoprecipitation, manually selected islets were
homogenized in RIPA buffer. Lysates were clarified by cen-
trifugation at 15,000 × g for 10 min. After protein content
determination, equal amounts of protein (500–600 μg)
were immunoprecipitated with anti-RasGrf1/2 antibody
(sc-224 Santa Cruz Inc, CA, USA) at 4°C.
The immune complexes were collected on protein A-
agarose beads (Upstate, CA, USA). Immunoprecipitates
were washed with lysis buffer and extracted for 5 min at
95°C in 4× SDS-PAGE sample buffer (200 mM Tris/HCl,
6% SDS, 2 mM EDTA, 4% 2-mercaptoethanol, 10% gly-
cerol, pH 6.8) and analyzed by SDS-PAGE.
Wild Type and mutant adult mice were anesthetized
with chloral hydrate (5% [wt/vol] in saline, 10 ml/g of
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the aorta, first with heparinized saline (5 IU/ml; Byk
Leo, Madrid, Spain) and then with a solution containing
4% (wt/vol) depolymerised paraformaldehyde and 0.2%
(wt/vol) picric acid in 0.1 M phosphate buffer (pH 7.4)
(PBS) for 20 min. Pancreas were dissected and postfixed
in the same solution for 2 h at 4°C. Paraffin embedded
Sections were stained using a Ventana Discovery XT
Staining Station. First antibodies and dilutions used
were as follows: Anti-Insulin (C27C9) Rabbit mAb (Cell
signalling Cat. No. 3014); Anti-Glucagon clone K79bB10,
ascites fluid (Sigma-aldrich G2654); Anti-Gria2 1:100
(Chemicon AB1768) and Anti-Phtf1 1:200 (generously
donated by Dr. Raich [96]). FITC-goat anti-Rabbit; CY3-
goat anti-mouse and HRP- goat anti-rabbit were used
as secondary antibodies for immunofluorescence and
immunocytochemistry respectively. Sections were then
washed in PBS, mounted in fluoromount Vectashield,
(Vector Laboratories) and cover slipped for viewing in
a Leica DM 6000B microscope. Images were acquired
using a Hamamatsu ORCA ER camera controlled with
the Metamorph image acquisition software.
Culture of pancreatic islets and BTC3 cells, transient
transfections and luciferase reporter assays
Manually isolated islets obtained as described [17] were
centrifuged in HBSS for 5 min at 250 × g. Supernatant
was discarded and islets were resuspended in 1.5 ml
HBSS 3 mM EGTA, 20 mg/ml BSA and 2.2 mg/ml glu-
cose. Islet solution was mixed with 48.5 ml trypsin solu-
tion (0.25% trypsin in PBS) and incubated for 10 minutes
at 37°C and 5% CO2. Islets were passed through a 20
gauge needle and centrifuged at 1500 rpm during 10 mi-
nutes. Cells were washed twice with PBS and cultured on
2 mg/ml collagen-coated (Roche, Switzerland) coverslips
in RPMI 10% FBS medium.
BTC3 cells [97] were grown in RPMI (Gibco) supple-
mented with fetal bovine serum (10% FBS; Hyclone, Logan,
Utah, USA), glutamine (2 mM), penicillin (100 U/ml) and
streptomycin (100 μg/ml), in a humidified tissue culture
incubator (Hera cell, Heraeus, Thermo Fisher Scientific
Inc.) at 5% CO2 and 37°C.
pBK-CMV RasGrf1 containing the full-length RasGrf1
coding sequence, and the reporter plasmid construct
pGL3-Pttg1 containing 2,3Kb promoter region, were
kindly supplied by Drs. D. Lowy and S. Melmed [81]
respectively. Cells were split into 12-well plates, and
each well was cotransfected, using Lipofectamine
2000® (Invitrogene), with 1 μg of a plasmid containing
the hPTTG1 promoter linked to luciferase and 1 μg
pBK-CMV RasGrf1, or 1 μg empty pBK-CMV vector as
control. pRL-Tk (Promega) encoding renilla luciferase
(5 ng/well) was used as an internal control to assess
transfection efficiency. 48 h hours after transfection cellswere stimulated with the indicated agonists/inhibitors for
7 h [Ionomycin 500 nM (Sigma), Epidermal Growth Factor
(EGF) 100 ng/ml (Peprotech), Lysophosphatidic acid
(LPA) 10 μM (Sigma), Insulin Growth Factor (IGF)
10 ng/ml (Sigma), U0126 (25 μM) (Promega), Wortmannin
100 nM (Sigma), SP600125 20 μM (Calbiochem)]. Whole-
cell lysates were collected for reporter detection by lucifer-
ase assays using a dual luciferase reporter kit (Promega,
Madison, WI, USA). Reactions were measured using a
Lumat LB 9507 Tube luminometer (Berthold Technolo-
gies GmbH & Co. KG).
Metabolic studies
Animals of the same sex were housed in type IIL individu-
ally ventilated cages, in a temperature- and humidity-
controlled room with a 12 h light/dark cycle, with food
(Teklad 2014, Harlan Laboratories) and water available
ad libitum. All testing was completed during the light
phase. Animal housing and experimentation followed
the general recommendations of the European Communi-
ties Council Directive of 86/609/EEC and the RD 1201/05
about the use of experimental animals with scientific aims.
Maximal efforts were made to minimize the total number
of animals as well as their suffering. All animal experimen-
tal procedures were approved by the local Animal Ethics
Committee of the University of Salamanca.
Blood for measuring plasma insulin levels [98] was
obtained by submandibular injection in mice anesthe-
tized by isofluorane inhalation (Abbot laboratories Ltd,
UK). Plasma insulin levels were measured by enzyme-
linked immunosorbent assay (Rat/Mouse Insulin ELISA
kit; Millipore). We performed glucose tolerance tests on
animals after a 14–16 h overnight fast. For these studies,
glucose (2 mg glucose/g body weight) was injected intra-
peritoneally. The One-way ANOVA test was used for stat-
istical analyses but whenever Levene’s test was significant,
we used Welch statistical result [99,100]. Bonferroni and
Gabriel post hoc tests were also used [101].
Availability of supporting data
All microarray hybridization data have been deposited and
are available at the NCBI, Gene Expression Omnibus
database (GEO accession series GSE56371; http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56371).
Additional files
Additional file 1: Table S1. Differential gene expression in pancreatic
islets of RasGrf1 KO mice. List of 4525 differentially expressed probesets
(3592 different genes) identified by means of SAM contrasts (FDR=0.084)
comparing the microarray-generated transcriptional profile of purified
pancreatic islets of RasGrf1 KO mice to those of WT control mice. Differentially
expressed loci are identified by Affymetrix Probeset ID, Symbol and Gene Name,
and listed according to degree of overexpression or repression, in
decreasing order of d-values. Red: overexpression. Green: repression.
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the calculated expression value of each gene probeset from the null
hypothesis (no-change). q-value is the estimated FDR at the largest
p-value for which the probe set would be statistically significant. R-fold
is a measure of the fold change of a probeset in the collection of
microarrays provided by the SAM algorithm. Values in red denote
overexpression. Values in green denote transcriptional repression.
NULL denotes probeset not recognizing any known transcribed mouse
genomic sequence.
Additional file 2: Figure S1. Transcriptional behavior of genomic
sequences located at the 3′ UTR terminal end of the RasGrf1 gene. (A)
Hybridization signals produced by Affymetrix probeset 1435614_s_at
recognizing the 3′ UTR region of the RasGrf1 locus. Bar plot showing
normalized hybridization signals produced by the 1435614_s_at probeset in
6 independent, separate microarray hybridizations with RNA from
pancreatic islets including 3 samples from RasGrf1 KO and 3 samples from
WT mice. (B) Localization of specific genomic sequences of the 3′ terminal
region of RasGrf1 gene that recognized by Affymetrix probesets and primer
oligonucleotides used in this study. The coding region is shown in capitals
and the 3′ UTR region is shown in italics. The position of the relevant
oligonucleotides mentioned in the text (LM5F, LM85R, MA5F, MA1F and
MA2R) is indicated by boxes and color changes as appropriate in each case.
(C) Confirmatory RT-PCR analysis of WT and RasGrf1 KO RNAs from pancre-
atic islets. The primer set LM5/LM85 amplifies the 3554–3829 nt region in
RasGrf1 mRNA sequence. Primer set MAF5/MA2R amplifies the 3830–4156
nt region, and the set MA1F/MA2R amplifies the 4012–4156 nt segment.
Specific oligonucleotides for GAPDH amplified a 90 bp band in both WT
and RasGrf1 KO RNA samples. Representative results of three independent
experiments are shown.
Additional file 3: Table S2A. Functional annotation of downregulated,
differentially expressed genes in pancreatic islets of RasGrf1 knockout
mice. The DAVID functional annotation tool (http://david.abcc.ncifcrf.gov/)
was used to identify statistically significant functional associations
(p-value <0.1) linking particular gene subsets contained within the list of
repressed loci occurring in RasGrf1 KO pancreatic islets (Additional file 1:
Table S1, FDR=0.084) to specific Gene Ontology (GO) terms. The column
labelled “Biological process” identifies the functional GO terms (level 5)
recognized in each case for the corresponding groups of loci listed
under the column labelled “Genes induced in RasGrf1KO pancreatic
islets (from Additional file 1: Table S1). The column labeled “Gene Count”
indicates the specific number of genes annotated by DAVID to the
indicated GO functionality within the list of repressed genes included in
Table S1 (Additional file 1). The values under the column “Percentage” are
calculated by referring the “Gene Count” numbers to the total number of
genes recognized by DAVID (1942, out of a total 1953) within that list.
The column labeled “p-value” refers to the statistical significance of the
functional associations identified, and contains p-values calculated using the
Hypergeometric Distribution and subsequently corrected by implementing
the False Discovery Rate (FDR) method [90].
Additional file 4: Table S2B. Functional annotation of upregulated,
differentially expressed genes in pancreatic islets of RasGrf1 knockout
mice. The DAVID functional annotation tool (http://david.abcc.ncifcrf.gov/)
was used to identify statistically significant functional associations
(p-value <0.1) linking particular gene subsets contained within the list
of induced loci occurring in RasGrf1 KO pancreatic islets (Additional file 1:
Table S1, FDR=0.084) to specific Gene Ontology (GO) terms. The column
labelled “Biological process” identifies the functional GO terms (level 5)
recognized in each case for the corresponding groups of loci listed
under the column labeled “Genes induced in RasGrf1 KO pancreatic islets
(from Additional file 1: Table S1)”. The column labeled “Gene Count”
indicates the specific number of genes annotated by DAVID to the
indicated GO functionality within the list of induced genes included in
Table S1 (Additional file 1). The values under the column “Percentage” are
calculated by referring the “Gene Count” numbers to the total number of
probesets recognized by DAVID (1781, out of a total 1799) within that list.
The column labeled “p-value” refers to the statistical significance of the
functional associations identified, and contains p-values calculated using the
Hypergeometric Distribution and subsequently corrected by implementing
the False Discovery Rate (FDR) method [90].Additional file 5: Table S3A. Altered KEGG pathways identified by
DAVID analysis of down-regulated (S3A), differentially expressed genes in
pancreatic islets of RasGrf1 knockout mice. The DAVID functional annotation
tool (http://david.abcc.ncifcrf.gov/) to identify statistically significant
functional associations linking particular gene subsets contained within
the list of repressed loci occurring in RasGrf1 KO pancreatic islets
(Additional file 1: Table S1, FDR=0.084) to specific KEGG pathways (Kyoto
Encyclopaedia of Genes and Genomes; www.genome.jp/kegg). The
“KEGG Pathway” column identifies the signaling pathway annotated in
each case to the corresponding group of loci listed in the column
labeled “Genes repressed in RasGrf1 KO pancreatic islets (from Additional
file 1: Table S1)”. The column labeled “Gene Count” indicates the specific
number of genes linked to the indicated signaling pathway within the
list of repressed genes included in Table S1 (Additional file 1). The values
under the column “Percentage” are calculated by referring the “Gene
Count” numbers to the total number of genes recognized by DAVID
(1943, out of a total 1953 genes, corresponding to 2268 probesets) within
that list. The column labeled “p-value” refers to the statistical significance of
the functional associations identified, and contains p-values calculated cases
using the Hypergeometric Distribution and subsequently corrected by
implementing the False Discovery Rate method [90].
Additional file 6: Table S3B. Altered KEGG pathways identified by
DAVID analysis of up-regulated, differentially expressed genes in pancreatic
islets of RasGrf1 knockout mice. The DAVID functional annotation tool
(http://david.abcc.ncifcrf.gov/) to identify statistically significant functional
associations linking particular gene subsets contained within the list of
induced loci occurring in RasGrf1 KO pancreatic islets (Additional file 1:
Table S1, FDR=0.084) to specific KEGG pathways (Kyoto Encyclopaedia of
Genes and Genomes; www.genome.jp/kegg). The “KEGG Pathway” column
identifies the signaling pathway annotated in each case to the corresponding
group of loci listed in the column labeled “Genes repressed in RasGrf1 KO
pancreatic islets (from Additional file 1: Table S1)”. The column labeled “Gene
Count” indicates the specific number of genes linked to the indicated signal-
ing pathway within the list of induced genes included in Table S1 (Additional
file 1). The values under the column “Percentage” are calculated by referring
the “Gene Count” numbers to the total number of genes recognized by DAVID
(1777, out of a total 1799 genes, corresponding to 2256 probesets) within that
list. The column labeled “p-value” refers to the statistical significance of the
functional associations identified, and contains p-values calculated cases
using the Hypergeometric Distribution and subsequently corrected by
implementing the False Discovery Rate method [90].
Additional file 7: Table S4. Concurrent transcriptional alterations at
different tissues of neuroectodermal origin in RasGrf1 KO mice. List of 29
different loci showing significant level of parallel, concomitant differential
gene expression in two or more separate microarray hybridization
analyses of samples from the indicated tissue locations of RasGrf1 KO
mice. Origin of the microarray expression data for each tissue was as
follows: Pancreatic islets: MOE430A arrays, Table S1 (Additional file 1) in
this work. LCM-purified hippocampus pyramidal cells: MOE430A arrays,
[32]. Retina: MOE430_2 arrays, [18]. Olfactory bulb, full hippocampus, and
brain cortex: Mouse Exon 1.0 ST arrays, unpublished data. Red: Upregulation.
Blue: Downregulation. LCM: Laser capture microdissection. No arrow: no
significant transcriptional change detected.
Additional file 8: Table S5A. Transcription factors identified by
functional annotation of differentially expressed, repressed genes in
RasGrf1 KO pancreatic islets. The GeneCodis functional annotation tool
(http://genecodis.cnb.csic.es/) was used to identify specific subsets within
the list of repressed genes of RasGrf1 KO pancreatic islets (Additional
file 1: Table S1, FDR=0.08; 2198 recognized repressed loci, out of a total
2268 probesets listed) that share co-occurrent functional annotations
linking them to specific Transcription Factors (TransFac database) at high
statistically significant p-values. The “Transcription Factor” column identifies
individual transcription factors recognized by GeneCodis as capable of
controlling expression of the corresponding groups of loci listed in each
case under the column labeled “Genes repressed in RasGrf1 KO pancreatic
islets”. The column labeled “Gene Count” indicates the specific number of
genes identified in each of those groups. Values in the “Percentage” column
are calculated referring the “Gene Count” column numbers to the total
number of repressed, input genes (2198 repressed loci from Additional file 1:
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column labeled “p-value” refers to the statistical significance of the
functional associations identified.
Additional file 9: Table S5B. Transcription factors identified by
functional annotation of differentially expressed, induced genes in
RasGrf1 KO pancreatic islets. The GeneCodis functional annotation tool
tool (http://genecodis.cnb.csic.es/) was used to identify specific subsets
within the list of induced genes of RasGrf1 KO pancreatic islets
(Additional file 1: Table S1, FDR=0.08; 2230 recognized overexpressed loci,
out of a total 2257 probesets listed) that share co-occurrent functional
annotations linking them to specific Transcription Factors (TransFac
database) at high statistically significant p-values. The “Transcription Factor”
column identifies individual transcription factors recognized by GeneCodis
as capable of controlling expression of the corresponding groups of loci
listed in each case under the column labeled “Genes induced in RasGrf1 KO
pancreatic islets”. The column labeled “Gene Count” indicates the specific
number of genes identified in each of those groups. Values in the
“Percentage” column are calculated referring the “Gene Count” column
numbers to the total number of induced, input genes (2198 repressed
loci from Additional file 1: Table S1) recognized by the functional
annotation software. The column labeled “p-value” refers to the
statistical significance of the functional associations identified.
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